Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

Anti-CD20 antibodies react with CD20 expressed not only on malignant B cells, but also on normal B cells. It has been reported that patients treated with anti-CD20 antibodies had an insufficient response to two-dose mRNA SARS-CoV-2 vaccination. To investigate the efficacy of a third dose in these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Yohei, Yakushijin, Kimikazu, Ohji, Goh, Hojo, Wataru, Sakai, Hironori, Watanabe, Marika, Kitao, Akihito, Miyata, Yoshiharu, Saito, Yasuyuki, Kawamoto, Shinichiro, Yamamoto, Katsuya, Ito, Mitsuhiro, Koyama, Taiji, Imamura, Yoshinori, Kiyota, Naomi, Matsuoka, Hiroshi, Mori, Yasuko, Minami, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229139/
https://www.ncbi.nlm.nih.gov/pubmed/35746573
http://dx.doi.org/10.3390/vaccines10060965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229139/
https://www.ncbi.nlm.nih.gov/pubmed/35746573
http://dx.doi.org/10.3390/vaccines10060965

Ejemplares similares